Beau left the lab in
June 2020 after working with us for 1 ½ years. During his time in our lab, Beau
pioneered our pipeline for testing drug combinations for synergy in cell lines
and patient samples. He also made significant contributions to multiple
projects through ex vivo drug sensitivity experiments and testing new potential
myeloma regimens using in vivo xenograft models. Beau is currently pursuing his MD at the Mayo Clinic in Scottsdale Arizona.
Denis left the lab in June 2020 after working with us for 1 year. During his time with our group, Denis created a bioinformatics pipeline for processing mass cytometry (CyTOF) data in Rstudio, and analyzing the output via machine learning algorithms. He also conducted our first single cell RNA sequencing experiment to interrogate myeloma subpopulations. After leaving the lab, Denis entered the MD, PhD program at Emory University.
American Society of Hematology Annual meeting, San Diego, 2018
Mount Bierstadt Summit, 14,065 feet